Shatoo 7 Tablets

Shatoo 7 Tablets

Description:

Shatoo 7 Tablets (SHATOO 50/200mg 7 C.R. F.C. TABS.) is a prescription anti‑Parkinson’s medicine that combines carbidopa and levodopa in a controlled‑release, film‑coated tablet. It is formulated to improve motor symptoms of Parkinson’s disease such as tremor, rigidity, bradykinesia (slowness of movement), and postural instability by restoring dopamine levels in the brain. The controlled‑release technology provides a more gradual and sustained delivery of levodopa, helping to reduce fluctuations in symptom control and extend the duration of benefit between doses. This product is intended for adult patients under the supervision of a neurologist or qualified physician.

Indications:

• Treatment of Parkinson’s disease (idiopathic parkinsonism).
• Treatment of Parkinsonian syndromes with symptoms such as muscle stiffness, tremor, slowness of movement, and difficulty with balance and coordination.
• Management of motor fluctuations ("wearing‑off" phenomena) in patients previously treated with levodopa alone or other levodopa combinations, as decided by the treating physician.

Active Ingredients / Key Components:

• Carbidopa – 50 mg per controlled‑release film‑coated tablet.
• Levodopa – 200 mg per controlled‑release film‑coated tablet.
• Pharmaceutical form: controlled‑release (C.R.) film‑coated tablet for oral use.
• Other excipients: full list of inactive ingredients is not available in the provided data; please refer to the printed package leaflet for complete excipient information.

Dosage & Administration / How to Use:

• Use only as prescribed by your doctor. Dosage must be individualized based on disease severity, previous levodopa therapy, and clinical response.
• Typical adult dosing: often started at a low dose and gradually increased. The exact starting dose and adjustment schedule are determined by the physician; specific dosing information is not available in the provided data.
• Administration: swallow the tablets whole with a glass of water. Do not crush, break, or chew, as this will interfere with the controlled‑release properties.
• May be taken with or without food. To improve absorption, some patients may benefit from taking it away from high‑protein meals; follow your doctor’s advice.
• If switching from immediate‑release levodopa or levodopa/carbidopa, your doctor will calculate an appropriate equivalent dose and schedule.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.
• Do not stop taking Shatoo 7 Tablets suddenly without medical advice, as abrupt withdrawal may worsen symptoms or, rarely, cause serious reactions.

Clinical Benefits:

• Helps replenish brain dopamine levels, improving motor control in Parkinson’s disease.
• Reduces key Parkinsonian symptoms such as tremor, muscle rigidity, and slowness of movement.
• Controlled‑release formulation provides more sustained symptom relief and may reduce "wearing‑off" between doses.
• Carbidopa component limits peripheral conversion of levodopa, enhancing levodopa availability to the brain and improving treatment efficacy.
• May reduce peripheral side effects of levodopa such as nausea and vomiting by decreasing dopamine formation outside the brain.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to carbidopa, levodopa, or any component of the formulation.
• Contraindicated in patients taking non‑selective monoamine oxidase (MAO) inhibitors; at least 14 days should elapse between stopping a non‑selective MAOI and starting Shatoo 7 Tablets.
• Contraindicated in narrow‑angle glaucoma.
• Use with caution in patients with severe cardiovascular or pulmonary disease, bronchial asthma, renal or hepatic impairment, endocrine disorders, or a history of peptic ulcer disease or convulsions.
• May cause or worsen dyskinesias (involuntary movements); dose adjustment may be required by the physician.
• May cause sudden onset of sleep or excessive daytime sleepiness; patients should be cautious when driving or operating machinery.
• Psychiatric effects such as hallucinations, confusion, or behavioral changes may occur, particularly in elderly patients or those with a history of psychiatric illness.
• Monitor for signs of depression and suicidal ideation; report mood changes to your doctor.
• Consult your doctor before use if pregnant, nursing, or planning pregnancy. Use only if the potential benefit justifies the potential risk.
• Consult your doctor before use if you have heart disease, arrhythmias, uncontrolled hypertension, glaucoma, liver disease, kidney disease, or a history of melanoma or suspicious skin lesions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, loss of appetite, dizziness, headache, dry mouth, and abdominal discomfort.
• Neurological side effects can include dyskinesias (involuntary movements), dystonia, and fluctuations in mobility.
• Psychiatric side effects may include hallucinations, confusion, agitation, insomnia, abnormal dreams, or mood changes.
• Cardiovascular effects such as postural hypotension (drop in blood pressure when standing), palpitations, or irregular heartbeat may occur in some patients.
• Other possible effects: sweating, fatigue, weakness, dark discoloration of saliva, urine, or sweat.
• Serious reactions such as severe allergic reactions, chest pain, severe dizziness or fainting, uncontrolled movements, or signs of gastrointestinal bleeding require immediate medical attention.
• If you experience sudden sleep episodes, severe mood changes, or suicidal thoughts, stop driving or operating machinery and contact your doctor immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: prescription anti‑Parkinson’s medicine.
• Active ingredients: carbidopa 50 mg + levodopa 200 mg per tablet.
• Form: controlled‑release film‑coated tablet.
• Pack size: 7 tablets per pack.
• Route of administration: oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.